Literature DB >> 18755341

Diagnosis and management of lymphatic vascular disease.

Stanley G Rockson1.   

Abstract

The lymphatic vasculature is comprised of a network of vessels that is essential both to fluid homeostasis and to the mediation of regional immune responses. In health, the lymphatic vasculature possesses the requisite transport capacity to accommodate the fluid load placed upon it. The most readily recognizable attribute of lymphatic vascular incompetence is the presence of the characteristic swelling of tissues, called lymphedema, which arises as a consequence of insufficient lymph transport. The diagnosis of lymphatic vascular disease relies heavily upon the physical examination. If the diagnosis remains in question, the presence of lymphatic vascular insufficiency can be ascertained through imaging, including indirect radionuclide lymphoscintigraphy. Beyond lymphoscintigraphy, clinically-relevant imaging modalities include magnetic resonance imaging and computerized axial tomography. The state-of-the-art therapeutic approach to lymphatic edema relies upon physiotherapeutic techniques. Complex decongestive physiotherapy is an empirically-derived, effective, multicomponent technique designed to reduce limb volume and maintain the health of the skin and supporting structures. The application of pharmacological therapies has been notably absent from the management strategies for lymphatic vascular insufficiency states. In general, drug-based approaches have been controversial at best. Surgical approaches to improve lymphatic flow through vascular reanastomosis have been, in large part, unsuccessful, but controlled liposuction affords lasting benefit in selected patients. In the future, specifically engineered molecular therapeutics may be designed to facilitate the controlled regrowth of damaged, dysfunctional, or obliterated lymphatic vasculature in order to circumvent or mitigate the vascular insufficiency that leads to edema and tissue destruction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755341     DOI: 10.1016/j.jacc.2008.06.005

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  33 in total

1.  Update on the biology and treatment of lymphedema.

Authors:  Stanley G Rockson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

2.  Sphingosine 1-phosphate receptor 1 regulates the directional migration of lymphatic endothelial cells in response to fluid shear stress.

Authors:  Vinay N Surya; Eleftheria Michalaki; Eva Y Huang; Gerald G Fuller; Alexander R Dunn
Journal:  J R Soc Interface       Date:  2016-12       Impact factor: 4.118

3.  Therapeutic effects of hyaluronidase on acquired lymphedema using a newly developed mouse limb model.

Authors:  Kangsan Roh; Sungrae Cho; Jae-Hyun Park; Byong Chul Yoo; Won-Ki Kim; Seok-Ki Kim; Kyewon Park; Hee Kang; Jin-Mo Ku; Chang-Hwan Yeom; Kyunghoon Lee; Sukchan Lee
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-16

4.  Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema.

Authors:  Joseph M Rutkowski; Carl Erik Markhus; Christina C Gyenge; Kari Alitalo; Helge Wiig; Melody A Swartz
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

5.  Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.

Authors:  Sandrine Levet; Delphine Ciais; Galina Merdzhanova; Christine Mallet; Teresa A Zimmers; Se-Jin Lee; Fabrice P Navarro; Isabelle Texier; Jean-Jacques Feige; Sabine Bailly; Daniel Vittet
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

Review 6.  Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.

Authors:  Kathryn H Schmitz
Journal:  Exerc Sport Sci Rev       Date:  2010-01       Impact factor: 6.230

7.  Interaction between vascularized lymph node transfer and recipient lymphatics after lymph node dissection-a pilot study in a canine model.

Authors:  Hiroo Suami; Mario F Scaglioni; Katherine A Dixon; Ramesh C Tailor
Journal:  J Surg Res       Date:  2016-05-26       Impact factor: 2.192

Review 8.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice.

Authors:  Kenta Nakamura; Kavita Radhakrishnan; Yat Man Wong; Stanley G Rockson
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 10.  G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases.

Authors:  William P Dunworth; Kathleen M Caron
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-05       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.